GO FUND IT NOW

Defense Health Agency Contracting Activity - DHACA

DoW Amyotrophic Lateral Sclerosis Research Program, Clinical Outcomes and Biomarkers Award

DoW Amyotrophic Lateral Sclerosis Research Program, Clinical Outcomes and Biomarkers Award is a funding opportunity from Defense Health Agency Contracting Activity - DHACA, closing September 30, 2026.

Funder
Defense Health Agency Contracting Activity - DHACA
Funding
Grant / contract
Deadline
Sep 30, 2026
(61d left)

Overview

Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Clinical Outcomes and Biomarkers Award (COBA) supports the development and/or validation of clinical outcomes and biomarkers to enrich clinical trials in amyotrophic lateral sclerosis (ALS). Projects can be relevant to a…

DoW Amyotrophic Lateral Sclerosis Research Program, Clinical Outcomes and Biomarkers Award | Go Fund It Now